IL99290A - Liquid pharmaceutical preparations containing liquid water-borne liquid water carrier and at least one polymer drug carrier - Google Patents

Liquid pharmaceutical preparations containing liquid water-borne liquid water carrier and at least one polymer drug carrier

Info

Publication number
IL99290A
IL99290A IL9929091A IL9929091A IL99290A IL 99290 A IL99290 A IL 99290A IL 9929091 A IL9929091 A IL 9929091A IL 9929091 A IL9929091 A IL 9929091A IL 99290 A IL99290 A IL 99290A
Authority
IL
Israel
Prior art keywords
drug delivery
nonaqueous
delivery vehicle
pharmaceutical compositions
liquid carrier
Prior art date
Application number
IL9929091A
Other languages
English (en)
Hebrew (he)
Other versions
IL99290A0 (en
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of IL99290A0 publication Critical patent/IL99290A0/xx
Publication of IL99290A publication Critical patent/IL99290A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL9929091A 1990-09-27 1991-08-23 Liquid pharmaceutical preparations containing liquid water-borne liquid water carrier and at least one polymer drug carrier IL99290A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/588,697 US5173298A (en) 1990-09-27 1990-09-27 Nonaqueous fluorinated drug delivery vehicle suspensions

Publications (2)

Publication Number Publication Date
IL99290A0 IL99290A0 (en) 1992-07-15
IL99290A true IL99290A (en) 1996-09-12

Family

ID=24354930

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9929091A IL99290A (en) 1990-09-27 1991-08-23 Liquid pharmaceutical preparations containing liquid water-borne liquid water carrier and at least one polymer drug carrier

Country Status (16)

Country Link
US (1) US5173298A (fr)
EP (1) EP0550615B1 (fr)
JP (1) JP3253072B2 (fr)
KR (1) KR100195760B1 (fr)
AT (1) ATE125696T1 (fr)
AU (1) AU656919B2 (fr)
CA (1) CA2090404C (fr)
DE (1) DE69111821T2 (fr)
ES (1) ES2075468T3 (fr)
IE (1) IE69016B1 (fr)
IL (1) IL99290A (fr)
NZ (1) NZ239558A (fr)
PT (1) PT99108B (fr)
TW (1) TW224428B (fr)
WO (1) WO1992005770A1 (fr)
ZA (1) ZA916770B (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048857A (en) * 1989-10-17 2000-04-11 Ellinwood, Jr.; Everett H. Dosing method of administering medicaments via inhalation administration
US5660851A (en) * 1989-12-26 1997-08-26 Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem Ocular inserts
IE67185B1 (en) * 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
AU640232B2 (en) * 1990-04-27 1993-08-19 Allergan, Inc. Polymeric drug delivery system
DE4201079C3 (de) * 1992-01-17 1997-09-11 Gramer Eugen Kombinationspräparate zur Augeninnendrucksenkung
WO1993018748A1 (fr) * 1992-03-19 1993-09-30 Allergan, Inc. Compositions contenant un vehicule d'administration de medicament en suspension dans un liquide fluore non aqueux
CZ286632B6 (cs) 1992-09-29 2000-05-17 Inhale Therapeutic Systems Farmaceutický prostředek
US5336487A (en) * 1993-03-05 1994-08-09 Refojo Miguel F Method of treating eye disorders with silicon/fluorosilicone copolymer oil
JPH10500148A (ja) 1994-03-04 1998-01-06 ユニバーシティ オブ ワシントン ブロック及びグラフトコポリマー並びにそれに関連する方法
DE4414755C2 (de) * 1994-04-27 2000-11-16 Lohmann Therapie Syst Lts Kollagenzubereitung zur gesteuerten Abgabe von Wirkstoffen, Verfahren und Verwendung
US5661029A (en) * 1994-05-12 1997-08-26 Biomed Biological culture growth and observation device
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
US6294563B1 (en) 1994-10-27 2001-09-25 Allergan Sales, Inc. Combinations of prostaglandins and brimonidine or derivatives thereof
EP0843565A4 (fr) * 1995-05-12 2002-10-16 Genentech Inc Administration d'un aerosol constitue de particules de grandes dimensions, contenant un produit a usage biologique
US5667809A (en) * 1995-06-07 1997-09-16 Alliance Pharmaceutical Corp. Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
US5861175A (en) 1996-03-15 1999-01-19 Alliance Pharmaceutical Corp. Use of fluorocarbons for diagnosis and treatment of articular disorders
WO1997045105A1 (fr) * 1996-05-24 1997-12-04 Angiotech Pharmaceuticals, Inc. Compositions et methodes pour traiter ou prevenir des maladies des voies corporelles
US5955096A (en) * 1996-06-25 1999-09-21 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
US20030077317A1 (en) * 1996-06-25 2003-04-24 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
US6090800A (en) * 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
GB9816724D0 (en) * 1998-08-01 1998-09-30 Boots Co Plc Therapeutic agents
CA2369739C (fr) * 1999-02-23 2008-12-16 Angiotech Pharmaceuticals, Inc. Compositions et methodes pour l'amelioration de l'integrite de cavites et de passages corporels affaiblis
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
AU6124601A (en) 2000-05-10 2001-11-20 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
CN1204922C (zh) * 2001-02-15 2005-06-08 株式会社三和化学研究所 新的眼科用组合物
MXPA04005865A (es) 2001-12-19 2004-09-13 Nektar Therapeutics Suministro de aminoglucosidos a los pulmones.
EP2284180B1 (fr) 2003-03-03 2015-09-09 Dyax Corp. Utilisations de peptides qui lient spécifiquement le récepteur HGF (cMET)
US20050118124A1 (en) * 2003-12-01 2005-06-02 Reinhart Gale M. Compositions for treating keratinous surfaces
US20050288197A1 (en) * 2004-06-08 2005-12-29 Ocularis Pharma, Inc. Silicone polymer topical eye compositions and methods of use
US8153435B1 (en) * 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
US20070219127A1 (en) * 2006-03-20 2007-09-20 Walt John G Cyclosporin a compositions
US8003621B2 (en) 2007-09-14 2011-08-23 Nitto Denko Corporation Drug carriers
US9057712B1 (en) 2011-10-27 2015-06-16 Copilot Ventures Fund Iii Llc Methods of delivery of encapsulated perfluorocarbon taggants

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911138B1 (en) * 1973-02-26 1996-10-29 Childrens Hosp Medical Center Artificial blood and method for supporting oxygen transport in animals
US4105798A (en) * 1976-07-19 1978-08-08 Sun Ventures, Inc. Perfluoro polycyclic compounds for use as synthetic blood and perfusion media
US4115544A (en) * 1976-08-18 1978-09-19 Alza Corporation Ocular system made of bioerodible esters having linear ether
WO1981000002A1 (fr) * 1979-06-25 1981-01-08 Suntech Utilisation de carbone perfluore pour le traitement des brulures
US4452818A (en) * 1982-03-19 1984-06-05 Haidt Sterling J Extraocular method of treating the eye with liquid perfluorocarbons
GR78151B (fr) * 1982-04-05 1984-09-26 Alcon Lab Inc
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4879304A (en) * 1987-05-01 1989-11-07 Angelini Pharmaceuticals Ltd. Ophthalmic compositions and process for preparing
US4882150A (en) * 1988-06-03 1989-11-21 Kaufman Herbert E Drug delivery system
US4865846A (en) * 1988-06-03 1989-09-12 Kaufman Herbert E Drug delivery system
FR2643572A1 (fr) * 1988-12-22 1990-08-31 Rhone Poulenc Chimie Procede d'encapsulation de particules par pelliculage au moyen d'un copolymere silicone thermoplastique

Also Published As

Publication number Publication date
AU656919B2 (en) 1995-02-23
DE69111821D1 (de) 1995-09-07
PT99108A (pt) 1993-11-30
PT99108B (pt) 1999-02-26
CA2090404C (fr) 2001-11-20
DE69111821T2 (de) 1995-12-14
WO1992005770A1 (fr) 1992-04-16
JPH06501258A (ja) 1994-02-10
IL99290A0 (en) 1992-07-15
ZA916770B (en) 1992-04-29
ATE125696T1 (de) 1995-08-15
KR100195760B1 (ko) 1999-06-15
AU8644291A (en) 1992-04-28
ES2075468T3 (es) 1995-10-01
TW224428B (fr) 1994-06-01
US5173298A (en) 1992-12-22
EP0550615B1 (fr) 1995-08-02
CA2090404A1 (fr) 1992-03-28
NZ239558A (en) 1993-10-26
EP0550615A1 (fr) 1993-07-14
JP3253072B2 (ja) 2002-02-04
IE69016B1 (en) 1996-07-24
IE913379A1 (en) 1992-04-08

Similar Documents

Publication Publication Date Title
EP0550615B1 (fr) Vehicules de liberation de medicaments en suspension dans un support perfluore non aqueux
US5518731A (en) Nonaqueous fluorinated drug delivery vehicle suspensions
US6458376B1 (en) Nonaqueous fluorinated drug delivery suspensions
US5480914A (en) Nonaqueous thixotropic drug delivery suspensions and methods of their use
US4001388A (en) Ophthalmological bioerodible drug dispensing formulation
US5441732A (en) Reversible gelation emulsion compositions and methods of use
US5599534A (en) Reversible gel-forming composition for sustained delivery of bio-affecting substances, and method of use
EP0322319B1 (fr) Composition contenant des implants oculaires biodégradables
US5888493A (en) Ophthalmic aqueous gel formulation and related methods
TWI292716B (en) Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US5516808A (en) Topical cellulose pharmaceutical formulation
AU2011317673B2 (en) Liquid pharmaceutical composition for the delivery of active ingredients
RU2460516C2 (ru) Офтальмические эмульсии масло-в-воде, содержащие простагландины
Aldrich et al. Ophthalmic preparations
JPS6322516A (ja) 制御放出性医薬組成物
WO1994005257A1 (fr) Liberation prolongee de medicaments ophtalmiques a partir d'un vehicule de diffusion de medicaments polymeres solubles
US4173226A (en) Device for administering solid drug particles to an eye
Lavik et al. Sustained delivery of timolol maleate for over 90 days by subconjunctival injection
US20070219127A1 (en) Cyclosporin a compositions
JPH0565221A (ja) 眼科用微小球
JP2021515758A (ja) ネビボロールを含む医薬組成物
CN116194091A (zh) 包含水凝胶和环孢菌素的持续释放可生物降解泪小管内插入物
AU2020404934A1 (en) Ophthalmic compositions comprising D2O
JPH08510731A (ja) 治療使用のためのその場で生成するゲル
WO1993018748A1 (fr) Compositions contenant un vehicule d'administration de medicament en suspension dans un liquide fluore non aqueux

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees